| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213340 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 29 Pages |
Abstract
Severe post-CRT lymphopenia is an independent predictor of poor OS in LAPC patients receiving CRT. Higher splenic doses increase the risk for the development of severe post-CRT lymphopenia. When clinically indicated, assessment of splenic DVHs before the acceptance of treatment plans may minimize the risk of severe post-CRT lymphopenia.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Awalpreet S. MD, Guan MD, Hsiang-Chun PhD, Prajnan MD, Bruce D. MD, Usama MD, Marc E. MD, Yelin PhD, Gabriel O. PhD, Sam PhD, Matthew H. MD, Jason B. MD, Milind M. MD, Gauri R. MD, Robert A. MD, Christopher H. MD, Xuemei MS, Howard PhD, Sunil MD,